Verici Dx (LON:VRCI) Trading Down 2.2% – Here’s What Happened

Shares of Verici Dx plc (LON:VRCI) dropped 2.2% during trading on Tuesday . The company traded as low as GBX 0.72 and last traded at GBX 0.76. Approximately 944,471 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 2,104,761 shares. The stock had previously closed at GBX 0.78.

Verici Dx Stock Down 9.0%

The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The firm has a market cap of £10.67 million, a P/E ratio of -0.24 and a beta of 1.59. The stock’s fifty day moving average is GBX 0.76 and its two-hundred day moving average is GBX 0.75.

Verici Dx Company Profile

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.